Bill Text: NJ A5495 | 2020-2021 | Regular Session | Amended

---

Bill Title: Permits certain paramedics to administer buprenorphine.

Spectrum: Partisan Bill (Democrat 6-0)

Status: (Introduced - Dead) 2021-06-21 - Substituted by S3803 (1R) [A5495 Detail]

Download: New_Jersey-2020-A5495-Amended.html

---

[First Reprint]

ASSEMBLY, No. 5495

STATE OF NEW JERSEY

219th LEGISLATURE

 

INTRODUCED MARCH 17, 2021

 

 

Sponsored by:

Assemblyman  HERB CONAWAY, JR.

District 7 (Burlington)

Assemblywoman  VALERIE VAINIERI HUTTLE

District 37 (Bergen)

Assemblyman  ANTHONY S. VERRELLI

District 15 (Hunterdon and Mercer)

 

Co-Sponsored by:

Assemblymen Armato and Benson

 

 

 

SYNOPSIS

     Permits certain paramedics to administer buprenorphine.

 

CURRENT VERSION OF TEXT

     As reported by the Assembly Health Committee on May 17, 2021, with amendments.

  

An Act concerning mobile intensive care paramedics and buprenorphine and supplementing Title 26 of the Revised Statutes.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    a.  As used in this section:

     "Mobile intensive care paramedic" and "mobile intensive care unit" shall have the same meaning as provided in section 1 of P.L.1984, c.146 (C.26:2K-7).

     "Opioid antidote" shall have the same meaning as provided in section 1 of P.L.2017, c.116 (C.26:2K-66).

     b.  Subject to the requirements of federal law, a mobile intensive care paramedic in this State who has responded to an emergency as a member of a dispatched mobile intensive care unit may administer buprenorphine ¹, under the medical direction of a licensed, supervising physician,¹ to an individual ¹[if a member of the mobile intensive care unit administered an opioid antidote to that individual] following the emergent administration of an opioid antidote to that individual¹ provided that the mobile intensive care paramedic administering the buprenorphine:

     (1)   is providing emergency medical services through a program that is registered with the United States Attorney General pursuant to subsection (j) of 21 U.S.C. s.823;

     (2)   administers the buprenorphine consistent with all applicable requirements of federal law; and

     (3)   has completed supervised comprehensive training and competency assessments within a mobile intensive care unit regarding which specific medical conditions necessitate the administration of buprenorphine, buprenorphine dosage requirements, and required medical documentation following the administration of buprenorphine.

 

     2.    The Commissioner of Health may adopt rules and regulations, in accordance with the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), as are necessary to effectuate the provisions of this act.

 

     3.    This act shall take effect immediately.